基本信息
views: 1
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
I have over 20 years experience in laboratory and clinical research of antimicrobial pharmacokinetics and pharmacodynamics in immunocompromised hosts. My current research focuses on the development of prognostic risk models and decision support tools for the diagnosis and treatment of fungal infections and multidrug resistant bacteria. I also serve as a Senior PK/PD Editor for the Journal of Antimicrobial Chemotherapy- the official journal of the British Society for Antimicrobial Chemotherapy.
Research Interests
Papers共 376 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of fungi (Basel, Switzerland)no. 6 (2024): 382
openalex(2023)
Current opinion in infectious diseasesno. 4 (2023): 250-256
Erin K. K. McCreary,Matthew R. R. Davis,Navaneeth Narayanan,David R. R. Andes, Dario Cattaneo, Robbie Christian,Russell E. E. Lewis,Kevin M. M. Watt,Nathan P. P. Wiederhold,Melissa D. D. Johnson
PHARMACOTHERAPYno. 10 (2023): 1043-1050
Joseph Pechacek, Taura Webb,Elise M N Ferré,Monica M Schmitt,Thomas DiMaggio,Dale Kobrin,Suraj Rajasimhan,Ben Colton,Russell E Lewis,David Andes, Alejandro Herrera,Dima Hammoud,
CURRENT FUNGAL INFECTION REPORTSno. 3 (2023): 250-261
Springer eBookspp.125-147, (2023)
Cited0Views0Bibtex
0
0
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022): 21-34
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn